Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Short-term Investments (2017 - 2022)

Selectis Health's Short-term Investments history spans 6 years, with the latest figure at $24387.0 for Q3 2022.

  • Quarterly results put Short-term Investments at $24387.0 for Q3 2022, changed 0.0% from a year ago — trailing twelve months through Sep 2022 was $24387.0 (changed 0.0% YoY), and the annual figure for FY2021 was $24387.0, changed 0.0%.
  • Short-term Investments for Q3 2022 was $24387.0 at Selectis Health, roughly flat from $24387.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $307895.0 in Q2 2018 to a low of $12134.0 in Q1 2019.
  • The 5-year median for Short-term Investments is $24387.0 (2019), against an average of $73348.6.
  • The sharpest move saw Short-term Investments skyrocketed 12963.0% in 2018, then tumbled 95.76% in 2019.
  • Year by year, Short-term Investments stood at $162106.0 in 2018, then plummeted by 84.96% to $24387.0 in 2019, then changed by 0.0% to $24387.0 in 2020, then changed by 0.0% to $24387.0 in 2021, then changed by 0.0% to $24387.0 in 2022.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $24387.0, $24387.0, and $24387.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.